CMS’s recent integration of health equity into its new and existing value-based payment (VBP) programs (as outlined below) signals a strong commitment to equitable care delivery. We expect health equity to be incorporated into additional federal programs and for private payers to follow CMS’s example in designing their own plans for managing the diverse needs … Read more

Leavitt Partners examined publicly available resources to determine the 340B Drug Pricing Program’s (340B) impact on drug prices charged by both covered entities and pharmaceutical manufacturers. To answer these questions, Leavitt Partners undertook a comprehensive literature review of publicly available governmental reports, peer-reviewed journal articles, white papers, news articles, and other publicly available sources to … Read more

Consumer health app developers are finding ways to help consumers and their physicians make better use of their health data. These apps can now get accredited for their compliance with best practices in managing personal health information, an important step towards building trust that consumers’ health data will be protected as it is moved more … Read more

Nonadherence to a prescribed medication regimen for patients with chronic pain is associated with overall lower health outcomes, including increased hospital admissions, costs, and morbidity (quantitative review here). Deviations in timing, dosage, frequency, or duration of medication—all components of noncompliance—can cause medical reactions, increased pain, and medication use disorders, and can ultimately lead to emergency care … Read more

In April 2022, we published a blog post exploring Q1 digital health funding within the US using a framework introduced by Leavitt Partners in a recently published whitepaper. Applying the same methods, we tracked funding across the digital health landscape In Q2. Q2 saw 144 deals in digital health for a total investment of $4.6 billion and an average deal … Read more

The COVID-19 pandemic significantly accelerated the demand for digital healthcare alternatives. As a result, private investors are looking for promising digital health startups or companies to financially back. One common problem investors will undoubtedly encounter when assessing opportunities in digital health is that stakeholders are often not speaking the same language. In February 2022, Leavitt Partners … Read more

While healthcare leaders seek to broaden and deepen their analysis of the implications of recent federal health policy changes, it is challenging to accurately determine where the industry might be headed in 2022 and beyond. On Tuesday, November 9, 2021, Leavitt Partners’ Senior Director of Health Policy Outreach, Jen Colamonico, moderated a Linkedin Live Political Checkpoint broadcast featuring Liz Wroe, … Read more

Nutrition’s role in better health outcomes (both physical and mental) and potential cost savings is spurring increased innovation within the healthcare sector. Providers are increasingly interested in how to best connect their patients to quality food, which means that health plans are figuring if (and how) they will reimburse for increasing nutrition security. Here are … Read more

On April 16, 2021, Leavitt Partners held its bi-annual Political Checkpoint webinar, featuring Governor Mike Leavitt, Andrew Croshaw, Clay Alspach, and Sara Singleton. The topic of the discussion was focused on how the future direction of U.S. health policy has been changed by the events of the past year. Governor Leavitt provided a flyover of 20 … Read more

Although the traumatic circumstances of the COVID-19 pandemic have exacerbated existing health inequities, it has also fueled an immediacy to address them. The CDC recently released two grant-funded initiatives for state and local health departments to mitigate COVID-19 related health disparities: With a combined estimated total program funding of $2.5 billion, many health departments will … Read more